| Literature DB >> 26921237 |
Kailai Wang1, Carmelo del Castillo2, Erwan Corre3, Emmanuelle Pales Espinosa4, Bassem Allam5.
Abstract
BACKGROUND: The hard clam Mercenaria mercenaria is an important seafood species widely exploited along the eastern coasts of the United States and play a crucial role in coastal ecology and economy. Severe hard clam mortalities have been associated with the protistan parasite QPX (Quahog Parasite Unknown). QPX infection establishes in pallial organs with the lesions typically characterized as nodules, which represent inflammatory masses formed by hemocyte infiltration and encapsulation of parasites. QPX infection is known to induce host changes on both the whole-organism level and at specific lesion areas, which imply systemic and focal defense responses, respectively. However, little is known about the molecular mechanisms underlying these alterations.Entities:
Mesh:
Year: 2016 PMID: 26921237 PMCID: PMC4769524 DOI: 10.1186/s12864-016-2493-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
RNA samples for RNA-seq libraries. Each pool is made with equal amounts of RNA from 3 individual clams. Pools A and B were derived from the same clams
| Library | Clams | Clam status | Tissue status | N paired-end reads | |
|---|---|---|---|---|---|
| Nodule | A1 | 1, 2, 3 | Diseased | Infection foci | 30,491,569 |
| A2 | 4, 5, 6 | Diseased | Infection foci | 34,515,597 | |
| A3 | 7, 8, 9 | Diseased | Infection foci | 46,861,893 | |
| Non-nodule | B1 | 1, 2, 3 | Diseased | Non-lesion/Healthy | 27,119,432 |
| B2 | 4, 5, 6 | Diseased | Non-lesion/Healthy | 28,254,720 | |
| B3 | 7, 8, 9 | Diseased | Non-lesion/Healthy | 40,259,333 | |
| Healthy | C1 | 10, 11, 12 | Healthy | Healthy | 36,714,347 |
| C2 | 13, 14, 15 | Healthy | Healthy | 43,293,545 | |
| C3 | 16, 17, 18 | Healthy | Healthy | 42,046,740 |
Fig. 1M. mercenaria de novo assembled transcriptome summary. a Transcriptome sequencing, assembly and annotation overview. b Assembled transcripts size distribution. c Distribution of the top 10 species with most homologues to M. mercenaria. Transcripts were searched using BLASTx against NCBI nr database with a cutoff value of E < 10E-03
Fig. 2Gene Ontology (GO) annotations of the M. mercenaria transcriptome. GO terms were identified by Blast2GO and the results were summarized in three main GO categories: biological process (8,168 annotations), cellular component (4,600 annotations), molecular function (4,231 annotations) at level-2
Fig. 3Number of transcripts expressed and reads coverage in each sample. a The X-axis indicates the sample (A1-A3: nodule; B1-B3: non-nodule; C1-C3: healthy, refer to Table 1 for more details). The Y-axis indicates the number of transcripts expressed in the samples. b Summary statistics of the reads coverage in each sample
Fig. 4Heatmap (a) and number of differentially expressed transcripts (b and c) across all samples (FDR ≤0.001, and |log2 (fold change)| >2). Over-expressed transcripts are shown in red in A and are enumerated in B. Under-expressed transcripts are shown in green in A and are enumerated in C. Replicate biological samples are displayed in A (see Table 1 for more details). For B and C: the cross-shaded areas inside each bar represent the number of transcripts with higher (B) or lower (C) expression levels in a condition as compared to the other two (e.g., the expression levels of 38 focally over-expressed transcripts in B were higher in nodule than in non-nodule tissues and healthy clams)
Transcripts with annotated functions (GO terms) related to immune recognition, signaling and regulation that were differentially expressed during M. mercenaria focal response against QPX. Additional information on these transcripts is given in Additional file 2. “Inf” designates an infinite fold change calculated for focal response as the expression of that transcript in non-nodule tissue was equal to 0
| Transcripts ID | Annotation | Regul-ation | Fold change | Function/GOs |
|---|---|---|---|---|
| Pathogen recognition receptors (PRRS) | ||||
| Scavenger receptors | ||||
| comp186077_c0_seq3 | somatomedin-b and thrombospondin type-1 domain-containing (RPE spondin) | Up | 71.3 | F:scavenger receptor activity; P:immune response; F:polysaccharide binding |
| comp179365_c0_seq8 | insulin-related peptide receptor | Up | 11.5 | F:scavenger receptor activity; P:transmembrane receptor protein tyrosine kinase signaling pathway |
| comp169098_c0_seq1 | hemicentin-1 | Up | 10.6 | F:scavenger receptor activity; P:cell adhesion |
| comp169486_c0_seq1 | lysyl oxidase-like protein 2 | Up | 22.5 | F:scavenger receptor activity; F:copper ion binding |
| comp192413_c0_seq18 | mam domain-containing glycosylphosphatidylinositol anchor protein 1 | Up | Inf | F:polysaccharide binding; F:scavenger receptor activity; P:immune response |
| C-type lectin (CTL) | ||||
| comp176879_c0_seq8 | c-type mannose receptor 2 | Up | 15.8 | F:binding; F:carbohydrate binding |
| comp190222_c0_seq3 | perlucin-like protein | Up | 49.1 | F:binding; F:carbohydrate binding; |
| Toll-like receptors (TLRs) | ||||
| comp189381_c0_seq1 | toll-like receptor 1 | Up | 16.5 | F:protein binding |
| comp190056_c0_seq8 | toll-like receptor e precursor | Down | Inf | P:signal transduction; F:protein binding |
| comp188195_c0_seq7 | toll-like receptor g precursor | Up | Inf | F:protein binding; P:signal transduction |
| comp189381_c1_seq2 | cell surface receptor tollo (toll 8) | Up | 10.9 | P:signal transduction; F:protein binding |
| Integrin | ||||
| comp189082_c0_seq13 | integrin alpha 4 | Up | Inf | P:cell-cell adhesion; C:integrin complex |
| comp189082_c0_seq24 | integrin alpha 4 | Up | 16.2 | P:cell-cell adhesion; C:integrin complex |
| comp185789_c0_seq4 | integrin alpha-ps | Up | 13.7 | P:cell adhesion; C:integrin complex |
| comp184975_c0_seq10 | integrin beta-1-like | Up | 12.4 | F:protein binding; F:receptor activity; |
| Low-density lipoprotein (LDL) | ||||
| comp181432_c3_seq2 | LDL receptor-related protein 12 | Up | 12.1 | - |
| comp187193_c1_seq4 | LDL receptor-related protein 12 | Up | Inf | F:protein binding |
| G-protein coupled receptor | ||||
| comp177186_c1_seq2 | G-protein coupled receptor partial | Up | 13.0 | P:cell surface receptor signaling pathway; F:transmembrane signaling receptor activity |
| comp191316_c2_seq1 | G-protein coupled receptor 64-like | Up | 28.1 | - |
| comp177657_c2_seq5 | guanine nucleotide-binding protein subunit | Up | Inf | P:G-protein coupled receptor signaling pathway; F:signal transducer activity |
| comp187628_c0_seq44 | substance-k (neurokinin) receptor | Up | 9.1 | P:G-protein coupled receptor signaling pathway; F:G-protein coupled receptor activity; |
| comp192446_c0_seq4 | orexin receptor type 2 | Up | 12.4 | P:G-protein coupled receptor signaling pathway; |
| Immune signaling and cell communication | ||||
| Phosphatase and kinases | ||||
| comp192546_c5_seq4 | immunoglobulin i-set domain protein | Up | 13.2 | F:protein serine/threonine kinase activity |
| comp165267_c0_seq3 | von willebrand factor type egf and pentraxin domain-containing protein | Up | 11.0 | F:protein tyrosine kinase activity |
| comp191437_c1_seq4 | focal adhesion kinase 1 | Up | 19.7 | F:signal transducer activity; |
| comp188649_c0_seq3 | calcium calmodulin-dependent protein kinase | Up | 9.3 | F:calmodulin-dependent protein kinase activity |
| comp190317_c0_seq7 | neuronal cell adhesion | Down | −13.3 | F:rhodopsin kinase activity |
| Rho signaling | ||||
| comp189234_c1_seq21 | rho gtpase-activating protein 15-like isoform x3 | Up | 18.1 | P:signal transduction |
| comp185122_c1_seq7 | rho gtpase-activating protein 24 | Up | 27.1 | P:signal transduction |
| comp187736_c1_seq25 | rho-related protein raca | Up | Inf | F:protein binding |
| comp188711_c0_seq2 | rho-associated protein kinase 2 | Up | Inf | P:intracellular signal transduction |
| Ubiquitin pathway | ||||
| comp190451_c2_seq9 | e3 ubiquitin-protein ligase hectd1 | Up | 164.9 | F:ubiquitin-protein ligase activity; F:metal ion binding |
| comp184512_c0_seq2 | e3 ubiquitin-protein ligase march6 | Up | 15.0 | F:zinc ion binding |
| comp192081_c0_seq1 | e3 ubiquitin-protein ligase ubr3 | Up | 8.7 | - |
| comp179031_c0_seq4 | cop9 signalosome complex subunit 5 | Up | Inf | F:protein binding |
| comp179031_c0_seq2 | cop9 signalosome complex subunit 5 | Up | Inf | F:protein binding |
| Wnt and Notch pathway | ||||
| comp185090_c0_seq10 | tyrosine-protein kinase ryk | Up | 26.3 | P:Wnt receptor signaling pathway |
| comp187449_c0_seq2 | fizzy-like protein | Up | 13.0 | F:protein binding |
| comp175460_c0_seq1 | neurogenic locus notch | Up | 11.7 | P:Notch signaling pathway; |
| comp182793_c0_seq5 | neurogenic locus notch protein | Up | 9.6 | P:G-protein coupled receptor signaling pathway |
| comp192565_c0_seq10 | nicastrin-like protein | Up | 12.6 | P:protein processing |
| Calcium mediated signal transduction | ||||
| comp183265_c0_seq1 | calmodulin 3b (phosphorylase delta) | Down | −11.6 | F:calcium ion binding |
| comp191993_c0_seq4 | EF-hand Ca-binding domain-containing protein 5 | Down | −10.9 | - |
| comp191855_c0_seq2 | EF-hand Ca-binding domain-containing protein 6 | Down | −15.9 | - |
| Complement pathway | ||||
| comp165285_c0_seq7 | macrophage-expressed gene 1 | Up | 11.5 | - |
| Signal transducer | ||||
| comp182953_c0_seq4 | signal recognition particle receptor subunit alpha | Up | 13.8 | F:signal recognition particle binding |
| comp182953_c0_seq5 | signal recognition particle receptor subunit alpha | Up | 73.0 | F:signal recognition particle binding |
| comp171563_c0_seq4 | gtp-binding nuclear protein | Up | Inf | P:small GTPase mediated signal transduction |
| comp188686_c0_seq19 | neuralized pats1 | Down | −758.9 | P:small GTPase mediated signal transduction |
| comp189853_c0_seq1 | unc5c-like protein | Down | −12.5 | P:signal transduction |
| Cell death regulation | ||||
| Apoptosis process | ||||
| comp175357_c1_seq16 | solute carrier family 25 member 38-like isoform 1 | Down | −25.0 | P:transmembrane transport |
| comp191590_c0_seq3 | p53-induced protein with a death domain isoform | Down | −39.1 | F:protein binding; P:signal transduction |
| comp191147_c0_seq62 | inhibitor of apoptosis | Up | 24.6 | - |
| comp191147_c0_seq70 | inhibitor of apoptosis | Up | Inf | F:metal ion binding; F:zinc ion binding; |
| comp191055_c2_seq4 | programmed cell death protein 10 | Up | 367.1 | - |
| comp190690_c2_seq9 | cell death abnormality protein 1-like | Up | Inf | F:binding; F:zinc ion binding |
| comp186101_c3_seq4 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Down | −10.8 | P:positive regulation of apoptotic process; P:negative regulation of wound healing; P:oxidation-reduction process; |
| Tumor necrosis factor (TNF) | ||||
| comp182922_c0_seq5 | TNF ligand superfamily member 10-like | Up | 8.5 | - |
| comp176786_c2_seq3 | TNF-like protein | Down | −26.3 | F:tumor necrosis factor receptor binding; P:immune response |
| TNF ligand superfamily member 10-like | Up | 8.5 | - | |
Transcripts with putative functions (GO terms) related to immune effectors that were differentially expressed during M. mercenaria focal response against QPX. Additional information on these transcripts is given in Additional file 2. “Inf” designates an infinite fold change calculated for focal response as the expression of that transcript in non-nodule tissue was equal to 0
| Transcripts ID | Annotation | Regula-tion | Fold change | Function/GOs |
|---|---|---|---|---|
| Oxidation-reduction processes | ||||
| comp186178_c0_seq12 | dual oxidase | Up | Inf | P:response to oxidative stress; P:oxidation-reduction process; F:peroxidase activity |
| comp185478_c0_seq4 | allene oxide synthase-lipoxygenase protein | Up | 10.0 | P:oxidation-reduction process; F:oxidoreductase activity; F:metal ion binding; |
| comp186926_c0_seq7 | c-terminal-binding protein | Up | Inf | P:oxidation-reduction process; F:NAD binding; |
| comp187462_c1_seq6 | chorion peroxidase | Up | 11.8 | P:oxidation-reduction process; P:response to oxidative stress; F:peroxidase activity |
| comp157634_c0_seq8 | cytochrome p450 | Up | 178.6 | P:oxidation-reduction process; F:oxidoreductase activity; F:iron ion binding |
| comp183426_c1_seq2 | dbh-like monooxygenase protein 1-like protein | Up | 24.8 | P:oxidation-reduction process; F:dopamine beta-monooxygenase activity; F:oxidoreductase activity |
| comp188723_c0_seq1 | isocitrate dehydrogenase | Up | Inf | P:oxidation-reduction process; F:magnesium ion binding; F:NAD binding |
| comp169486_c0_seq1 | lysyl oxidase-like protein 2 | Up | 22.5 | F:oxidoreductase activity; P:oxidation-reduction process; F:scavenger receptor activity |
| comp192316_c0_seq4 | methylenetetrahydrofolate reductase | Up | Inf | P:oxidation-reduction process; F:methylenetetrahydrofolate reductase (NADPH) activity; |
| comp189621_c0_seq4 | procollagen-oxoglutarate 5-dioxygenase 3 | Up | 9.7 | P:oxidation-reduction process; F:iron ion binding |
| comp185148_c0_seq6 | ww domain-containing oxidoreductase | Up | Inf | F:oxidoreductase activity; P:metabolic process |
| Protease | ||||
| comp184786_c1_seq4 | fur protein precursor | Up | Inf | F:serine-type endopeptidase activity |
| comp180950_c0_seq5 | lysosomal protective protein precursor | Up | 47.1 | F:serine-type carboxypeptidase activity |
| comp180950_c0_seq2 | lysosomal protective protein precursor | Up | 26.9 | F:serine-type carboxypeptidase activity |
| comp189961_c0_seq12 | N-acetylated-alpha-linked acidic dipeptidase 2 | Up | 16.3 | F:metallopeptidase activity; |
| comp178551_c1_seq1 | membrane metallo-endopeptidase-like 1-like | Up | Inf | F:metalloendopeptidase activity; |
| comp184011_c0_seq4 | blastula protease 10 | Up | 8.1 | F:metalloendopeptidase activity; |
| comp191868_c1_seq1 | matrix metalloproteinase-19 | Up | 59.1 | - |
| comp174947_c0_seq3 | isoaspartyl peptidase l-asparaginase-like | Up | Inf | F:hydrolase activity |
| comp183848_c0_seq3 | kyphoscoliosis peptidase | Down | −8.7 | P:microtubule-based movement |
| comp188831_c0_seq3 | puromycin-sensitive aminopeptidase-like isoform | Down | −65.5 | F:metallopeptidase activity; |
| comp191458_c3_seq5 | aspartic protease with reverse transcriptase activity | Down | −245.4 | F:aspartic-type endopeptidase activity; |
| Protease inhibitor | ||||
| comp189919_c1_seq4 | alpha macroglobulin | Up | 21.9 | F:endopeptidase inhibitor activity |
| comp189919_c1_seq2 | alpha macroglobulin | Up | 12.4 | F:endopeptidase inhibitor activity |
| comp181286_c4_seq1 | thioester-containing protein | Up | 10.2 | F:endopeptidase inhibitor activity |
| comp191416_c1_seq2 | thioester-containing protein-a | Up | 14.8 | F:endopeptidase inhibitor activity |
| comp191416_c1_seq1 | thioester-containing protein-b | Up | 9.5 | F:endopeptidase inhibitor activity |
| comp192366_c0_seq1 | thioester-containing protein-c | Up | 32.5 | F:endopeptidase inhibitor activity |
| comp191416_c0_seq5 | thioester-containing protein-e | Up | 12.9 | F:endopeptidase inhibitor activity |
| comp191416_c0_seq4 | thioester-containing protein-e | Up | 22.4 | F:endopeptidase inhibitor activity |
| Ion transporter and sequester | ||||
| comp190604_c1_seq1 | ceruloplasmin precursor | Up | 21.8 | P:copper ion transport; P:cellular iron ion homeostasis; F:ferroxidase activity |
| comp182612_c1_seq1 | ferric-chelate reductase 1 | Up | 16.7 | Iron transfer |
| comp180332_c1_seq1 | ferric-chelate reductase 1-like | Up | 11.8 | Iron transfer |
| comp177359_c0_seq1 | selenium binding protein | Down | −11.0 | P:protein transport; F:selenium binding |
| comp174164_c0_seq20 | divalent metal transporter | Up | 328.2 | P:transport; F:transporter activity |
| Wound repair | ||||
| comp185425_c1_seq1 | actin-related protein 2 3 complex subunit 5-like | Up | Inf | C:cytoskeleton; P:regulation of actin filament polymerization |
| comp93954_c0_seq1 | extracellular matrix protein 2 isoform1 | Up | 25.9 | F:protein binding |
| comp188753_c5_seq1 | cartilage matrix protein | Up | 25.8 | F:chitin binding; P:chitin metabolic process; C:extracellular region |
| comp142858_c0_seq1 | epidermal growth factor-like protein 8-like | Up | 18.5 | F:protein binding; F:calcium ion binding |
| comp192650_c1_seq4 | multiple epidermal growth factor-like domains 6 | Up | 21.9 | F:protein binding |
| comp186665_c0_seq1 | thrombospondin- partial | Up | 106.9 | F:protein binding |
| comp186665_c0_seq4 | thrombospondin- partial | Up | 38.0 | F:protein binding |
| comp184960_c0_seq4 | septin-7-like isoform 8 | Up | Inf | P:cell cycle; F:GTP binding; C:septin complex |
| comp184960_c0_seq42 | septin-7-like isoform 6 | Up | 8.9 | - |
Selected transcripts with annotated functions (GO terms) related to immune response that were over-expressed during M. mercenaria systemic response against QPX. Additional information on these transcripts is given in Additional file 3. “Inf” designates an infinite fold change calculated for focal response as the expression of that transcript in non-nodule tissue was equal to 0
| Transcripts ID | Annotation | Regul-ation | Fold change | Function/GOs |
|---|---|---|---|---|
| Stress protein | ||||
| comp39934_c1_seq1 | heat shock 70 kda protein | Up | Inf | P:response to stress |
| comp181704_c3_seq49 | heat shock 70 kda protein 12b | Up | 452.9 | - |
| comp68505_c0_seq1 | heat shock protein 70 | Up | 37.8 | P:response to stress |
| comp38810_c0_seq1 | hsp90 family member | Up | 64.7 | P:response to stress |
| comp192296_c2_seq3 | usp-like protein isoform 2 | Up | 46.2 | P:response to stress |
| Immune effectors | ||||
| comp192209_c0_seq3 | hemocyte defensin partial | Up | 173.5 | P:defense response |
| comp186386_c5_seq2 | c-type lysozyme 2 | Up | 20.0 | - |
| comp186386_c5_seq1 | c-type lysozyme 2 | Up | Inf | - |
| comp164821_c0_seq2 | c1q domain containing protein | Up | 8.3 | Lectin |
| comp164821_c0_seq3 | c1q domain containing protein | Up | 11.9 | Lectin |
| comp190576_c0_seq27 | low affinity immunoglobulin epsilon fc receptor | Up | 134.1 | F:carbohydrate binding; Lectin |
| comp190576_c0_seq26 | low affinity immunoglobulin epsilon fc receptor | Up | 201.6 | F:carbohydrate binding; Lectin |
| comp191987_c0_seq10 | macrophage mannose receptor 1-like | Up | 7.8 | F:carbohydrate binding; Lectin |
| comp189507_c1_seq9 | ferric-chelate reductase 1 | Up | 10.7 | Iron transport |
| Peptidases | ||||
| comp156268_c1_seq1 | cathepsin k-like | Up | 9.5 | - |
| comp184090_c0_seq6 | calpain 11-like | Up | 10.1 | - |
| comp189096_c0_seq4 | counting factor associated protein d-like | Up | 36.1 | F:cysteine-type peptidase activity |
| comp176418_c0_seq1 | isoaspartyl peptidase | Up | 8.0 | F:hydrolase activity |
| Anti-apoptotic factors | ||||
| comp178822_c0_seq1 | interleukin IL17-like | Up | 11.6 | P:inflammatory response; F:cytokine activity |
| comp176786_c2_seq3 | deoxyguanosine mitochondrial | Up | 29.5 | F:tumor necrosis factor receptor binding; P:immune response; |
| comp192603_c1_seq8 | baculoviral iap repeat-containing protein 7-a | Up | 10.3 | P:negative regulation of peptidase activity |
| comp192603_c1_seq7 | baculoviral iap repeat-containing protein 7-a | Up | 14.3 | P:negative regulation of peptidase activity |
| comp191786_c0_seq3 | baculoviral iap repeat-containing protein partial | Up | 8.9 | - |
Fig. 5Significantly enriched KEGG pathways in M. mercenaria derived from the differentially expressed (DE) genes during focal (a) and systemic (b) response against QPX. The KEGG pathways having significant enrichment (P < 0.01) are presented, and the bar shows the x-fold enrichment of each KEGG pathway. Pathways involved in immune response are marked with red dots while metabolism-related pathways are marked with green dots
Fig. 6Overview of immune-related enriched pathways of differentially expressed (DE) transcripts during M. mercenaria response to QPX. a Schematic diagram of enriched pathways and their interactions. Only pathway components encoded by DE transcripts (shown in text boxes) are presented within each enriched KEGG pathway (framed in orthogonal polygons). Arrows display possible interactions (e.g., activation, inhibition) between pathway components. b Overview of DE transcripts expression associated with enriched pathways in nodule, non-nodule and healthy M. mercenaria tissues. The red and green heatmap values indicate log2 fold of relative expression levels for individual transcripts. Arp2/3: actin related protein 2/3 complex; CtBP: C-terminal binding protein; CAMK2: calcium/calmodulin-dependent protein kinase (CaM kinase) II; CycD: cyclin D1(CCND1); ECM: von Willebrand factor; ENDO-G: endonuclease G; FAK: focal adhesion kinase; FYN: tyrosine-protein kinase; HES1: hairy and enhancer of split 1; IAP: baculoviral IAP repeat-containing protein, cIAPs; ITGA: intergrin alpha; ITGB: intergrin beta; MLCP: serine/threonine-protein phosphatase PP1 catalytic subunit; NRXN: neurexin; NCSTN: nicastrin; Rac: Ras-related C3 botulinum toxin substrate; ROCK: Rho-associated protein kinase; RTK: proto-oncogene tyrosine-protein kinase; SELE: selectin, endothelial cell; SELP: selectin, platelet; TRAIL: tumor necrosis factor ligand superfamily member 10); WNT: wingless-type MMTV integration site family
Selected transcripts with annotated functions (GO terms) related to immune response that were differentially expressed in naïve M. mercenaria as compared to QPX infected individuals. Additional information on these transcripts is given in Additional file 4. “Inf” designates an infinite fold change calculated for focal response as the expression of that transcript in non-nodule tissue was equal to 0
| Transcripts ID | Annotation | Fold change | Function/GOs |
|---|---|---|---|
| Over-expressed | |||
| comp168250_c0_seq2 | macrophage expressed protein | 84.0 | - |
| comp160023_c0_seq1 | serine protease inhibitor 1 | 18.1 | F:protein binding |
| comp117137_c0_seq1 | proline-rich transmembrane protein 1 | 148.6 | P:response to biotic stimulus |
| comp134883_c0_seq1 | c-type lectin domain family 10 member a-like | 121.4 | F:carbohydrate binding |
| comp180146_c3_seq31 | aplysianin a precursor | Inf | P:defense response; F:oxidoreductase activity |
| comp179365_c0_seq7 | insulin-related peptide receptor | 20.0 | F:scavenger receptor activity |
| comp187368_c2_seq9 | apoptosis 1 inhibitor | 16.2 | P:apoptotic process; |
| comp193015_c0_seq1 | baculoviral iap repeat-containing protein 4 | 391.0 | P:negative regulation of apoptotic process; F:ubiquitin-protein ligase activity |
| Under-expressed | |||
| comp39934_c1_seq1 | heat shock 70 kda protein | Inf | P:response to stress |
| comp192296_c2_seq3 | usp-like protein isoform 2 | −46.2 | P:response to stress |
| comp169961_c0_seq2 | cytochrome p450 1a1 | −75.1 | - |
| comp176418_c0_seq1 | isoaspartyl peptidase l-asparaginase-like | −8.0 | F:hydrolase activity |
| comp191987_c0_seq10 | macrophage mannose receptor 1-like | −7.8 | F:carbohydrate binding |
| comp186563_c0_seq7 | bile salt-activated lipase-like | −9.8 | F:hydrolase activity |